Birdwatch Archive

Birdwatch Note Rating

2024-04-01 18:51:15 UTC - NOT_HELPFUL

Rated by Participant: 470CC13033B310EC5CC165F7B6362A2A6BDB5F563D8AEAE4BC201A911D695E51
Participant Details

Original Note:

Novo Nordisk spent over $2B in R&D over half a decade to make develop Ozempic. https://en.wikipedia.org/wiki/Semaglutide https://www.macrotrends.net/stocks/charts/NVO/novo-nordisk/research-development-expenses

All Note Details

Original Tweet

All Information

  • noteId - 1774520608384246241
  • participantId -
  • raterParticipantId - 470CC13033B310EC5CC165F7B6362A2A6BDB5F563D8AEAE4BC201A911D695E51
  • createdAtMillis - 1711997475400
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 1
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 1
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 1
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 1
  • ratingsId - 1774520608384246241470CC13033B310EC5CC165F7B6362A2A6BDB5F563D8AEAE4BC201A911D695E51